Pemetrexed Waverley 500 mg inj. sol. (pwdr., conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pemetrexed waverley 500 mg inj. sol. (pwdr., conc.) i.v. vial

waverley pharma europe ltd. - pemetrexed disodium - eq. pemetrexed 500 mg - powder for concentrate for solution for infusion - 500 mg - pemetrexed disodium - pemetrexed

Pemetrexed Sandoz 25 mg/ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pemetrexed sandoz 25 mg/ml inf. sol. (conc.) i.v. vial

sandoz sa-nv - pemetrexed disodium hemipentahydrate 30,2 mg/ml - eq. pemetrexed 25 mg/ml - concentrate for solution for infusion - 25 mg/ml - pemetrexed disodium hemipentahydrate 30.2 mg/ml - pemetrexed

Pemetrexed Sandoz 25 mg/ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pemetrexed sandoz 25 mg/ml inf. sol. (conc.) i.v. vial

sandoz sa-nv - pemetrexed disodium hemipentahydrate 30,2 mg/ml - eq. pemetrexed 25 mg/ml - concentrate for solution for infusion - 25 mg/ml - pemetrexed disodium hemipentahydrate 30.2 mg/ml - pemetrexed

Pemetrexed Sandoz 25 mg/ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pemetrexed sandoz 25 mg/ml inf. sol. (conc.) i.v. vial

sandoz sa-nv - pemetrexed disodium hemipentahydrate 30,2 mg/ml - eq. pemetrexed 25 mg/ml - concentrate for solution for infusion - 25 mg/ml - pemetrexed disodium hemipentahydrate 30.2 mg/ml - pemetrexed

Pemetrexed Ever Pharma 25 mg/ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pemetrexed ever pharma 25 mg/ml inf. sol. (conc.) i.v. vial

ever valinject gmbh - pemetrexed disodium hemipentahydrate 30,2 mg/ml - eq. pemetrexed 25 mg/ml - concentrate for solution for infusion - 25 mg/ml - pemetrexed disodium hemipentahydrate 30.2 mg/ml - pemetrexed

Pemetrexed Ever Pharma 25 mg/ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pemetrexed ever pharma 25 mg/ml inf. sol. (conc.) i.v. vial

ever valinject gmbh - pemetrexed disodium hemipentahydrate 30,2 mg/ml - eq. pemetrexed 25 mg/ml - concentrate for solution for infusion - 25 mg/ml - pemetrexed disodium hemipentahydrate 30.2 mg/ml - pemetrexed

Pemetrexed Ever Pharma 25 mg/ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pemetrexed ever pharma 25 mg/ml inf. sol. (conc.) i.v. vial

ever valinject gmbh - pemetrexed disodium hemipentahydrate 30,2 mg/ml - eq. pemetrexed 25 mg/ml - concentrate for solution for infusion - 25 mg/ml - pemetrexed disodium hemipentahydrate 30.2 mg/ml - pemetrexed

PEMETREXED SEACROSS 100 MG Israel - English - Ministry of Health

pemetrexed seacross 100 mg

a.l. medi-market ltd. - pemetrexed as disodium - powder for concentrate for solution for infusion - pemetrexed as disodium 100 mg/vial - pemetrexed - pemetrexed seacross in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. pemetrexed seacross in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed seacross is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed seacross is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy.

PEMETREXED SEACROSS 500 MG Israel - English - Ministry of Health

pemetrexed seacross 500 mg

a.l. medi-market ltd. - pemetrexed as disodium - powder for concentrate for solution for infusion - pemetrexed as disodium 500 mg/vial - pemetrexed - pemetrexed seacross in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. pemetrexed seacross in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed seacross is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed seacross is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy.

PEMETREXED DISODIUM FOR INJECTION POWDER FOR SOLUTION Canada - English - Health Canada

pemetrexed disodium for injection powder for solution

jamp pharma corporation - pemetrexed (pemetrexed disodium) - powder for solution - 100mg - pemetrexed (pemetrexed disodium) 100mg